Sweden
Joined October 2009
- Tweets1.1K
- Following1.7K
- Followers288
- Likes723
Now this is an interesting trial. CT planning and guidance is in many ways a logical next step for interventional epicardial cardiology. Structural heart has shown us that pre-planning is beneficial and possible. Should PCI be treated the same way perhaps?
Presented at #TCT2026:
In a randomized trial, CCTA-guided PCI with structured preprocedural planning and intraprocedural guidance was noninferior to intravascular ultrasound–guided PCI with respect to target-vessel failure at 12 months. Full P4 trial results: nej.md/48jfVly
@crfheart
ALT A graph from the Original Article "Coronary CT Angiography versus Intravascular Ultrasound Guidance for PCI." The trial name, P4, is in parentheses after the title. The graph shows the cumulative incidence of target-vessel failure (primary end point), defined as a composite of death from cardiac causes, target-vessel myocardial infarction, or ischemia-driven target-vessel revascularization, at 12 months. The trial results are being presented at the Transcatheter Cardiovascular Therapeutics 2026 Conference. The logo of the New England Journal of Medicine is at the bottom.
Christoffer H. Bach retweeted
Timely state of the art paper!
This aligns well with several of the angles we covered during the @BCIS_uk Grand Rounds last week when Adrian Banning (Senior author of the OPTIMAL trial) presented to a panel including @twj1974 @DrPeterOKane @kvm83
millbrook-events.co.uk/event…
Christoffer H. Bach retweeted
Meta-analyses of intravascular imaging guidance of PCI show markedly improved outcomes, but only if you use this tool properly — pre-, intra- and post-PCI and with appropriate targets. How do you do it? Our new state-of-the-art review in EHJ takes you through it step by step.
Christoffer H. Bach retweeted
Presented at #ESCCongress:
Among 16,808 adults without known cardiovascular disease, silent atherosclerosis was present in 57.1%, was detectable in early adulthood, and became more prevalent and extensive with age in a sex-dependent pattern. Full REACT trial results: nej.md/46gp1hP
@escardio
ALT A graph from the Original Article "Prevalence of Silent Atherosclerosis across Adult Life." The trial name, REACT, is in parentheses after the title. The graph shows a cross-sectional age pattern of silent atherosclerosis prevalence in men and women. The trial results are being presented at the European Society of Cardiology Congress 2026. The logo of the New England Journal of Medicine is at the bottom.
Christoffer H. Bach retweeted
Great question! We were puzzled by this trend and that was prompted us to analyze the 10X larger dataset from Swedeheart showing some interesting differences between iFR and FFR in terms of decision and demographics, but no difference in MACE, death,MI or revasc.
Good News for Intravascular Imaging Continues at 5 Years: RENOVATE-COMPLEX-PCI tctmd.com/news/good-news-int…
Christoffer H. Bach retweeted
Excimer laser coronary atherectomy is experiencing renewed interest in complex PCI.
This viewpoint revisits the “5 Ss” rule and introduces 3 additional principles to guide contemporary ELCA practice.
eurointervention.pcronline.c…
#InterventionalCardiology #PCI #ElCalentao
@JuradoRomanAl @mattiabasile
Christoffer H. Bach retweeted
Our study on outcomes of OCT/IVUS vs. angio guidance of DES in 2005 severely calcified lsns in ECLIPSE publ in JACC CV Int. Img used in 62% (dr discretion) associated with 26% adj decr in TVF. Consistent w/orbital atherectomy or balloon vessel prep. Link authors.elsevier.com/sd/arti…
Christoffer H. Bach retweeted
Provocative study from the RENOVATE trialists and Samsung Med Cntr suggesting use of intravascular imaging may eliminate long-term diffs between CABG & PCI. Not definitive absent a powered RCT, but should be enough to mandate IVI in these pts, esp with class I guidelines. Agree?
Christoffer H. Bach retweeted
🎙️ Our new podcast Turning Point launches today!
In Episode 1, Patrick W. Serruys joins host @aayshacader to reflect on a life of bold choices, innovation & mentorship.
🎧 Listen now: bit.ly/4520lbQ
Christoffer H. Bach retweeted
IVUS is the winner. happy to see that very few are still angio-based. CT will be coming. and surprise about OCT...the ability to measure Ca thickness is not enough? @PCRonline @ColletCarlos @JEscaned @mirvatalasnag
Christoffer H. Bach retweeted
🎙 #Podcast
In this episode, Prof. @JEscaned guides us through the “dark side of the moon” of #CAD — #INOCA, vasomotor disorders, and the underrecognized burden of non-obstructive #angina.
🔗prev-interv.com/2025/07/14/p…
🎧open.spotify.com/episode/0ox…
#CardioEd #Atherosclerosis #Cardiology
Christoffer H. Bach retweeted
Thank you for all the great feedback following the presentation of our novel fenestration technique at #EuroPCR2025 today!
Our approach was:
> Simple - anyone can learn
> Available - no specialized tools
> Fast - less than 5 minutes needed for all 14 operators to complete
Christoffer H. Bach retweeted
Thanks a lot! The technique we developed uses a small balloon as support and inflated stent-balloon to “bounce” off at the level of the carina. We tested this method and found it was reproducible among 14 operators with different skill levels (6mo-20y) and also fastest.
Good heart advice from my cardiologist friend @drandrewsharp.
From CAD to ACAD! Potentially saving millions of lives.
Our Commission, now published in The Lancet, advocates redefining coronary artery disease as atherosclerotic coronary artery disease (ACAD). This shift moves beyond the traditional ischemia-centered model to a systematic approach addressing atherosclerosis earlier. We believe this reframing will enable earlier identification and management, with the potential to save millions of lives worldwide.
Commission: thelancet.com/journals/lance…
Editorial: thelancet.com/journals/lance…
Comment: thelancet.com/journals/lance…
Christoffer H. Bach retweeted
Our 2021 IAMI flu vaccine trial continues to make waves - first shaping European guidelines with a 1A recommendation, now the same in the American version.
@SVRaoMD @Globalbiosec @mmamas1973 @MGtberg @drjohnm @DLBHATTMD @StabellBenn @cpgale3 @DrMarthaGulati @LGHemkens
Christoffer H. Bach retweeted
NEW! 2025 US guidelines for the management of ACS (STEMI and NSTE-ACS) just released. Intravascular imaging guidance with OCT or IVUS during PCI in ACS is now recommended for left main or complex lesions with a class IA recommendation.
Christoffer H. Bach retweeted
Check out this #JACCINT interview with @MGtberg discussing the long term #outcomes of #IFR vs #FFR guided #coronary revascularization; insights from the #SWEDEHEART registry🫀👇🏽
jacc.org/doi/10.1016/j.jcin.…
@JACCJournals #CardioX #ACCFIT